Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Caldara

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 1, 1980
Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemiaC Ferrari, P G Crosignani, R Caldara, et al.
Diabetologia|August 1, 1991
Neurophysiological study of the effect of combined kidney and pancreas transplantation on diabetic neuropathy: a 2-year follow-up evaluationG Comi, G Galardi, S Amadio, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patientsC Ferrari, C Barbieri, R Caldara, et al.
Neuroendocrinology|April 1, 1981
Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in womenC Ferrari, R Caldara, C Barbieri, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 1999
Insulin secretory patterns and blood glucose homeostasis after islet allotransplantation in IDDM patients: comparison with segmental- or whole-pancreas transplanted patients through a long term longitudinal studyA Secchi, M V Taglietti, C Socci, et al.
Transplantation Proceedings|June 1, 1992
Metabolic results at 6 and 12 months after pancreas transplantationA Sousa-Castello, N Lefrancois, X Martin, et al.
Metabolism: Clinical and Experimental|October 1, 1978
Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjectsC Ferrari, R Caldara, P Rampini, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1984
Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergolineA M Mattei, C Ferrari, G Ragni, et al.
Clinical Endocrinology|March 1, 1994
Cholelithiasis and acromegaly: therapeutic strategiesM Montini, D Gianola, M D Pagani, et al.
Fertility and Sterility|September 1, 1979
Metergoline treatment of hyperprolactinemic statesP G Crosignani, C Ferrari, A Mattei, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|January 1, 1980
Failure of nomifensine administration to discriminate between tumorous and nontumorous hyperprolactinemiaC Ferrari, P G Crosignani, R Caldara, et al.
Diabetologia|August 1, 1991
Neurophysiological study of the effect of combined kidney and pancreas transplantation on diabetic neuropathy: a 2-year follow-up evaluationG Comi, G Galardi, S Amadio, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patientsC Ferrari, C Barbieri, R Caldara, et al.
Neuroendocrinology|April 1, 1981
Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in womenC Ferrari, R Caldara, C Barbieri, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 4, 1999
Insulin secretory patterns and blood glucose homeostasis after islet allotransplantation in IDDM patients: comparison with segmental- or whole-pancreas transplanted patients through a long term longitudinal studyA Secchi, M V Taglietti, C Socci, et al.
Transplantation Proceedings|June 1, 1992
Metabolic results at 6 and 12 months after pancreas transplantationA Sousa-Castello, N Lefrancois, X Martin, et al.
Metabolism: Clinical and Experimental|October 1, 1978
Inhibition of prolactin release by serotonin antagonists in hyperprolactinemic subjectsC Ferrari, R Caldara, P Rampini, et al.
British Journal of Obstetrics and Gynaecology|March 1, 1984
Serum prolactin and ovarian function after discontinuation of drug treatment for hyperprolactinaemia: a study with bromocriptine and metergolineA M Mattei, C Ferrari, G Ragni, et al.
Clinical Endocrinology|March 1, 1994
Cholelithiasis and acromegaly: therapeutic strategiesM Montini, D Gianola, M D Pagani, et al.
Fertility and Sterility|September 1, 1979
Metergoline treatment of hyperprolactinemic statesP G Crosignani, C Ferrari, A Mattei, et al.
Pageof 11